Entera Bio Ltd. (ENTX): Insider Trading, Congress Trades & Research | Tormere

ENTX

$3.05-1.29%visit website

Entera Bio Ltd.

Market Cap

$525M

Live price × Finnhub shares (2026-10-17)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.46

60mo monthly vs SPY

P/E (TTM)

—

Price / TTM diluted EPS

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

—

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of revenue	0.00	0.00	0.00	0.00	0.00
Gross profit	0.00	0.00	0.00	0.00	0.00
Research & development	1,643	1,718	2,251	3,201	8,813
Selling, general & administrative	122	54	128	124	428
Total operating expenses	3,256	3,042	3,539	4,563	14,400
Operating income	(3,256)	(3,042)	(3,539)	(4,563)	(14,400)
Net income	(3,200)	(3,016)	(3,505)	(7,312)	(17,033)
EPS (basic) ($)	0.07		0.07	0.14	0.35
EPS (diluted) ($)	0.07		0.07	0.14	0.35
Weighted avg. shares (basic)	47,090		47,756	50,451
Weighted avg. shares (diluted)	47,090		47,756	50,451

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 7, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 18 more quarters, back to Mar 2021, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

Analyst Consensus

Strong Buy

11 analysts

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-03-09	2026-03-11	Germano Geno J	Director	Purchase	20.0K	$1.30	$26K	40.0K	View
2026-03-05	2026-03-09	Ellis Sean	Director	Purchase	10.0K	$1.23	$12K	188.1K	View

Reporting Insiders

Recent News

CABA,PFX,ELUT,ZBIO,HYPD,ALT,SELF,ENTX,SRBK,MAIA,LUCK,PCF,GAIA,MDRR,CFBK,SPMC,GEF-B,MDBH,IRIX,RAL,RNXT,AIRJ | Stock Prices | Quote Comparison - Yahoo Finance

Yahoo! Finance Canada · 2026-11-04

CABA,PFX,ELUT,ZBIO,HYPD,ALT,SELF,ENTX,BLIN,LUCK,PCF,GAIA,MDRR,CFBK,VSTS,SPMC,GEF-B,FRD,MDBH,IRIX,RAL,RNXT,AIRJ | Stock Prices | Quote Comparison - Yahoo Finance

Yahoo! Finance Canada · 2026-11-04

CABA,PFX,ELUT,HYPD,ZBIO,SELF,ENTX,SRBK,MAIA,PCF,LUCK,MDRR,GAIA,SPMC,GEF-B,MDBH,IRIX,BOTJ,RAL,RNXT,AIRJ,SCKT | Stock Prices | Quote Comparison - Yahoo Finance

Yahoo! Finance Canada · 2026-11-03

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga · 2026-10-30

Why Civeo Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Benzinga · 2026-10-30

Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors

Yahoo · 2026-10-27

A women’s health leader with more than 20 years developing medicines joins Entera’s board Dec. 1.

Stock Titan · 2026-10-27

Eloxx Pharmaceuticals Appoints Biopharmaceutical Industry Veteran Geno Germano to its Board of Directors

Yahoo · 2026-10-19

Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at ASBMR 2026 Annual Meeting

Yahoo · 2026-10-13

Entera Bio Presents Phase 2 Data Supporting EB613 Benefits In Women With Osteoporosis At ASBMR 2026 Annual Meeting

Benzinga · 2026-10-13

These stocks are moving in today's pre-market session

ChartMill · 2026-10-09

Alignment Healthcare, RenX Enterprises And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

Benzinga · 2026-10-09

Entera Bio Announces Additional Presentation of EB613 Phase 3 Study Design at the ASBMR 2026 Annual Meeting

Yahoo · 2026-10-08

Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise

Yahoo · 2026-10-06

Entera to Participate in Upcoming Fall Investor Conferences

Yahoo Finance · 2026-08-27

Informational purposes only, not investment advice.